Antibacterial resistance worldwide: causes, challenges and responses

[1]  S. Levy,et al.  Targeting virulence to prevent infection: to kill or not to kill? , 2004 .

[2]  S. Amyes,et al.  Microbiology and drug resistance mechanisms of fully resistant pathogens. , 2004, Current opinion in microbiology.

[3]  H. Gold,et al.  Antimicrobial resistance to linezolid. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  B S Cooper,et al.  Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature , 2004, BMJ : British Medical Journal.

[5]  S. Schrag,et al.  Emergence of Streptococcus pneumoniae with Very-High-Level Resistance to Penicillin , 2004, Antimicrobial Agents and Chemotherapy.

[6]  France Gauvin,et al.  Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  J. Maurer,et al.  Gram-positive bacteria are a major reservoir of Class 1 antibiotic resistance integrons in poultry litter. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[8]  G. Jacoby,et al.  Emerging Plasmid-Mediated Quinolone Resistance Associated with the qnr Gene in Klebsiella pneumoniae Clinical Isolates in the United States , 2004, Antimicrobial Agents and Chemotherapy.

[9]  H. Goossens,et al.  International Prospective Study of Klebsiella pneumoniae Bacteremia: Implications of Extended-Spectrum -Lactamase Production in Nosocomial Infections , 2004, Annals of Internal Medicine.

[10]  S. McAllister,et al.  Vancomycin-Resistant Staphylococcus aureus Isolate from a Patient in Pennsylvania , 2004, Antimicrobial Agents and Chemotherapy.

[11]  D. Livermore.  Can better prescribing turn the tide of resistance? , 2004, Nature Reviews Microbiology.

[12]  Stephen F Eckel,et al.  Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  K Kümmerer,et al.  Promoting resistance by the emission of antibiotics from hospitals and households into effluent. , 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[14]  J. Shetty,et al.  Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus , 2003, Science.

[15]  S. Projan,et al.  Why is big Pharma getting out of antibacterial drug discovery? , 2003, Current opinion in microbiology.

[16]  M. V. Lee,et al.  Multidrug-resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime-Hawaii, 2001. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  S. Amyes,et al.  Role of AcrR and RamA in Fluoroquinolone Resistance in Clinical Klebsiella pneumoniae Isolates from Singapore , 2003, Antimicrobial Agents and Chemotherapy.

[18]  F. Vandenesch,et al.  Community-Acquired Methicillin-Resistant Staphylococcus aureus Carrying Panton-Valentine Leukocidin Genes: Worldwide Emergence , 2003, Emerging infectious diseases.

[19]  M. Athanasiou,et al.  Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients , 2003, Critical care.

[20]  F. Tubau,et al.  Viridans Group Streptococci Are Donors in Horizontal Transfer of Topoisomerase IV Genes to Streptococcus pneumoniae , 2003, Antimicrobial Agents and Chemotherapy.

[21]  Marc Lipsitch,et al.  Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States , 2003, Nature Medicine.

[22]  S. Cosgrove,et al.  Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  A. Holck,et al.  Frequency of Disinfectant Resistance Genes and Genetic Linkage with β-Lactamase Transposon Tn552 among Clinical Staphylococci , 2002, Antimicrobial Agents and Chemotherapy.

[24]  J. Karlowsky,et al.  Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of Escherichia coli from Female Outpatients in the United States , 2002, Antimicrobial Agents and Chemotherapy.

[25]  Arjun Srinivasan,et al.  Vancomycin Resistance in Staphylococci , 2002, Clinical Microbiology Reviews.

[26]  P. Nordmann,et al.  Emerging carbapenemases in Gram-negative aerobes. , 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[27]  A. Vidaver.  Uses of antimicrobials in plant agriculture. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  A. Summers.  Generally overlooked fundamentals of bacterial genetics and ecology. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  S. Levy,et al.  The 2000 Garrod lecture. Factors impacting on the problem of antibiotic resistance. , 2002, The Journal of antimicrobial chemotherapy.

[30]  H. Weinstock,et al.  Increases in fluoroquinolone-resistant Neisseria gonorrhoeae--Hawaii and California, 2001. , 2002, MMWR. Morbidity and mortality weekly report.

[31]  S. Levy,et al.  Carriage of antibiotic-resistant fecal bacteria in Nepal reflects proximity to Kathmandu. , 2001, The Journal of infectious diseases.

[32]  P. Bradford.  Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat , 2001, Clinical Microbiology Reviews.

[33]  S. Levy.  Antibiotic resistance: consequences of inaction. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  S. Levy,et al.  Genetic Characterization of Highly Fluoroquinolone-Resistant Clinical Escherichia coli Strains from China: Role ofacrR Mutations , 2001, Antimicrobial Agents and Chemotherapy.

[35]  G. Eliopoulos,et al.  New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  R. Weinstein.  Controlling antimicrobial resistance in hospitals: infection control and use of antibiotics. , 2001, Emerging infectious diseases.

[37]  B. Erickson.  Gene transfer in the environment. , 2001, Environmental science & technology.

[38]  Ames,et al.  WIDESPREAD DISTRIBUTION OF URINARY TRACT INFECTIONS CAUSED BY A MULTIDRUG-RESISTANT ESCHERICHIA COLI CLONAL GROUP , 2001 .

[39]  R. Weinstein,et al.  Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  N. Woodford,et al.  Carbapenemases: a problem in waiting? , 2000, Current opinion in microbiology.

[41]  S. Levy,et al.  The impact of antibiotic use on resistance development and persistence. , 2000, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[42]  I. Kobayashi,et al.  Antimicrobial Resistance of Neisseria gonorrhoeae and High Prevalence of Ciprofloxacin-Resistant Isolates in Japan, 1993 to 1998 , 2000, Journal of Clinical Microbiology.

[43]  H. Goossens,et al.  The epidemiology of vancomycin-resistant enterococci. , 1999, Current opinion in infectious diseases.

[44]  I. Lasota,et al.  Debating Democracy Assistance: Sometimes Less Is More , 1999 .

[45]  Julian I. Rood,et al.  Nomenclature for New Tetracycline Resistance Determinants , 1999, Antimicrobial Agents and Chemotherapy.

[46]  R M Hall,et al.  Mobile Gene Cassettes and Integrons in Evolution , 1999, Annals of the New York Academy of Sciences.

[47]  Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus — Minnesota and North Dakota, 1997-1999. , 1999, MMWR. Morbidity and mortality weekly report.

[48]  From the Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus--Minnesota and North Dakota, 1997-1999. , 1999, JAMA.

[49]  R. Rubin,et al.  The economic impact of Staphylococcus aureus infection in New York City hospitals. , 1999, Emerging infectious diseases.

[50]  J J Schentag,et al.  Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada. , 1998, Diagnostic microbiology and infectious disease.

[51]  G. Jacoby,et al.  Quinolone resistance from a transferable plasmid , 1998, The Lancet.

[52]  S. Levy,et al.  The challenge of antibiotic resistance. , 1998, Scientific American.

[53]  D. Lauderdale,et al.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. , 1998, JAMA.

[54]  S. Levy.  Antibiotic resistance: an ecological imbalance. , 2007, Ciba Foundation symposium.

[55]  S. Levy,et al.  Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon , 1997, Antimicrobial agents and chemotherapy.

[56]  P Huovinen,et al.  The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. , 1997, The New England journal of medicine.

[57]  J. Cove,et al.  Sequential antibiotic therapy for acne promotes the carriage of resistant staphylococci on the skin of contacts. , 1996, The Journal of antimicrobial chemotherapy.

[58]  A. Wilkins.  Antibiotic resistance: Origins, evolution and spread , 1996 .

[59]  M. Roberts,et al.  Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution. , 1996, FEMS microbiology reviews.

[60]  H. Nikaido.  Multidrug efflux pumps of gram-negative bacteria , 1996, Journal of bacteriology.

[61]  J. T. Crawford,et al.  Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. , 1996, JAMA.

[62]  D. Cohn.  Treatment of multidrug-resistant tuberculosis. , 1995, The Journal of hospital infection.

[63]  S. Levy.  Balancing the drug-resistance equation. , 1994, Trends in microbiology.

[64]  B. Spratt,et al.  Origin and molecular epidemiology of penicillin-binding-protein-mediated resistance to beta-lactam antibiotics. , 1994, Trends in microbiology.

[65]  B. Spratt.  Resistance to antibiotics mediated by target alterations. , 1994, Science.

[66]  M. Arthur,et al.  Genetics and mechanisms of glycopeptide resistance in enterococci , 1993, Antimicrobial Agents and Chemotherapy.

[67]  A. Tomasz,et al.  Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. , 1993, The Journal of infectious diseases.

[68]  W. Roper,et al.  Initial therapy for tuberculosis in the era of multidrug resistance. Recommendations of the Advisory Council for the Elimination of Tuberculosis. , 1993, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[69]  M. Kocur,et al.  Trends in microbiology , 1992, World journal of microbiology & biotechnology.

[70]  Christopher J. L. Murray,et al.  Tuberculosis: Commentary on a Reemergent Killer , 1992, Science.

[71]  S. Levy,et al.  Active efflux mechanisms for antimicrobial resistance , 1992, Antimicrobial Agents and Chemotherapy.

[72]  S. Levy,et al.  Inter- and intraspecies spread of Escherichia coli in a farm environment in the absence of antibiotic usage. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[73]  S. Levy.  Starting life resistance-free. , 1990, The New England journal of medicine.

[74]  C. Phelps.  Bug/Drug Resistance: Sometimes Less is More , 1989, Medical care.

[75]  R. Munro,et al.  A national survey of antimicrobial resistance in Staphylococcus aureus in Australian teaching hospitals , 1989, The Medical journal of Australia.

[76]  S. Levy,et al.  High frequency of antimicrobial resistance in human fecal flora , 1988, Antimicrobial Agents and Chemotherapy.

[77]  D. Corpet.  Antibiotic resistance from food. , 1988, The New England journal of medicine.

[78]  S. Solomon,et al.  Health and economic impacts of antimicrobial resistance. , 1987, Reviews of infectious diseases.

[79]  D. Clewell,et al.  Conjugative transposons and the dissemination of antibiotic resistance in streptococci. , 1986, Annual review of microbiology.

[80]  S. Levy,et al.  Antibiotic-resistant bacteria in wild primates: increased prevalence in baboons feeding on human refuse , 1985, Applied and environmental microbiology.

[81]  S. Levy,et al.  Homogeneity of transferable tetracycline-resistance determinants in Haemophilus species. , 1984, The Journal of infectious diseases.

[82]  S. Levy.  44 – ANTIBIOTIC-RESISTANT BACTERIA IN FOOD OF MAN AND ANIMALS , 1984 .

[83]  StuartB Levy,et al.  MICROBIAL RESISTANCE TO ANTIBIOTICS An Evolving and Persistent Problem , 1982, The Lancet.

[84]  E. Wong,et al.  Common R-plasmids in Staphylococcus aureus and Staphylococcus epidermidis during a nosocomial Staphylococcus aureus outbreak , 1982, Antimicrobial Agents and Chemotherapy.

[85]  S. Levy.  Emergence of antibiotic-resistant bacteria in the intestinal flora of farm inhabitants. , 1978, The Journal of infectious diseases.

[86]  S. Falkow,et al.  Plasmid-Mediated Beta-Lactamase Production in Neisseria gonorrhoeae , 1977, Antimicrobial Agents and Chemotherapy.

[87]  J. V. van Embden,et al.  Plasmid-Mediated Chloramphenicol Resistance in Haemophilus influenzae , 1977, Antimicrobial Agents and Chemotherapy.

[88]  J. Møller,et al.  Changing Patterns of Plasmid-Mediated Drug Resistance During Tetracycline Therapy , 1977, Antimicrobial Agents and Chemotherapy.

[89]  S. Levy,et al.  Changes in intestinal flora of farm personnel after introduction of a tetracycline-supplemented feed on a farm. , 1976, The New England journal of medicine.

[90]  S. Falkow,et al.  Molecular nature of two beta-lactamase-specifying plasmids isolated from Haemophilus influenzae type b , 1976, Journal of bacteriology.

[91]  T. Szasz.  Bad habits are not diseases. A refutation of the claim that alcoholism is a disease. , 1972, The Lancet.

[92]  N. Datta,et al.  R Factors in Escherichia coli in faeces after oral chemotherapy in general practice. , 1971, Lancet.

[93]  T. Watanabe.  Infective heredity of multiple drug resistance in bacteria. , 1963, Bacteriological reviews.

[94]  D. Mitchison,et al.  Streptomycin Resistance in Pulmonary Tuberculosis , 1948, British medical journal.

[95]  M. Barber,et al.  Infection by penicillin-resistant staphylococci. , 1948, Lancet.